Australia's most trusted
source of pharma news
Posted 6 August 2026 PM
Former J&J boss Gary Bird has been named the new CEO of the Perth-based sterile injectable hospital medicines supplier LumaCina.
Bird takes the helm as the company, part of the Bridgewest Group, is expanding its portfolio through an acquisition and licensing program and broadening its presence across Australian and international markets, LumaCina said. It supplies medicines including Morphine, Lidocaine, IV fluids and antiseptics to customers in Australia, New Zealand, Asia and northern Europe.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.